Showing results (261-270 of 389) with videos related to
Sort By:
Pageof 39
Zeitschrift Fur Gastroenterologie|June 7, 2022
[Position paper on reporting of intestinal ultrasound findings in patients with inflammatory bowel disease]Torsten Kucharzik, Raja Atreya, Oliver Bachmann, et al.Journal of Crohn'S & Colitis|August 11, 2023
Myenteric Plexus Immune Cell Infiltrations and Neurotransmitter Expression in Crohn's Disease and Ulcerative ColitisJakob J Wiese, Subhakankha Manna, Anja A Kühl, et al.Journal of Crohn'S & Colitis|January 29, 2016
High-resolution Quantitative Computed Tomography Demonstrates Structural Defects in Cortical and Trabecular Bone in IBD PatientsJudith Haschka, Simon Hirschmann, Arnd Kleyer, et al.Journal of Crohn'S & Colitis|July 6, 2022
PU.1-driven Th9 Cells Promote Colorectal Cancer in Experimental Colitis Models Through Il-6 Effects in Intestinal Epithelial CellsKatharina Gerlach, Vanessa Popp, Stefan Wirtz, et al.Nature Immunology|June 9, 2014
TH9 cells that express the transcription factor PU.1 drive T cell-mediated colitis via IL-9 receptor signaling in intestinal epithelial cellsKatharina Gerlach, YouYi Hwang, Alexej Nikolaev, et al.Journal of Crohn'S & Colitis|November 1, 2024
Risankizumab Is Associated With Normalization of Biomarkers in Patients With Crohn's Disease: Results From the Phase 3 ADVANCE, MOTIVATE, and FORTIFY StudiesRaja Atreya, Marc Ferrante, Remo Panaccione, et al.Zeitschrift Fur Gastroenterologie|July 20, 2021
[Position paper on endoscopic reporting in IBD]Carsten Schmidt, Oliver Bachmann, Daniel C Baumgart, et al.Frontiers in Immunology|May 19, 2023
Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosisKristina Koop, Karin Enderle, Miriam Hillmann, et al.Inflammatory Bowel Diseases|July 31, 2023
Real-World Effectiveness of Vedolizumab vs Anti-TNF in Biologic-naïve Crohn's Disease Patients: A 2-year Propensity-score-adjusted Analysis from the VEDOIBD-StudyBernd Bokemeyer, Sandra Plachta-Danielzik, Romina di Giuseppe, et al.Translational Research : the Journal of Laboratory and Clinical Medicine|October 22, 2022
Expression and function of α4β7 integrin predict the success of vedolizumab treatment in inflammatory bowel diseaseInes Schneider, Clarissa Allner, Laura Mühl, et al.Pageof 39